quinapril has been researched along with Kidney Diseases in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Godo, M; Gross, ML; Hamar, P; Kokeny, G; Mózes, M; Nemeth, Z; Ritz, E; Rosivall, L | 1 |
| Allen, TJ; Burrell, LM; Candido, R; Cooper, ME; Davis, BJ; Jandeleit-Dahm, K; Johnston, CI; Lassila, M | 1 |
| Akashiba, A; Honda, T; Ishimitsu, T; Kameda, T; Matsuoka, H; Minami, J; Ohta, S; Ono, H; Takahashi, M; Takahashi, T; Yoshii, M | 1 |
| Cruickshank, HE | 1 |
| Blot, S; Chatellier, G; Michel, JB; Philippe, M; Xu, Y | 1 |
| Ferder, LF; Inserra, F; Porter, JR; Reisin, E; Richards, RJ; Stella, I; Svec, F | 1 |
| Bernal, R; Blanco, J; Egido, J; Gomez-Garre, D; Gomez-Guerrero, C; Lopez-Franco, O; Ortega, L; Sugaya, T; Suzuki, Y; Tejera, N | 1 |
| Abraham, PA; Halstenson, CE; Horvath, AM; Olson, SC; Opsahl, JA; Posvar, EL; Rachael, K | 1 |
| Bailey, RR; Begg, EJ; Frank, GJ; Lynn, KL; Olson, SC; Robson, RA | 1 |
1 review(s) available for quinapril and Kidney Diseases
| Article | Year |
|---|---|
The pharmacokinetics of angiotensin converting enzyme inhibitors in patients with renal impairment.
Topics: Angiotensin-Converting Enzyme Inhibitors; Creatinine; Humans; Isoquinolines; Kidney Diseases; Osmolar Concentration; Quinapril; Tetrahydroisoquinolines; Time Factors | 1989 |
8 other study(ies) available for quinapril and Kidney Diseases
| Article | Year |
|---|---|
Increased renoprotection with ACE inhibitor plus aldosterone antagonist as compared to monotherapies--the effect on podocytes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Drug Therapy, Combination; Kidney Diseases; Male; Mineralocorticoid Receptor Antagonists; Podocytes; Quinapril; Rats; Rats, Sprague-Dawley; Spironolactone; Tetrahydroisoquinolines | 2009 |
Anti-atherosclerotic and renoprotective effects of combined angiotensin-converting enzyme and neutral endopeptidase inhibition in diabetic apolipoprotein E-knockout mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Apolipoproteins E; Atherosclerosis; Biomarkers; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus; Glycated Hemoglobin; Kidney; Kidney Diseases; Male; Mice; Mice, Knockout; Neprilysin; Organ Size; Peptidyl-Dipeptidase A; Protease Inhibitors; Pyridines; Quinapril; Tetrahydroisoquinolines; Thiazepines | 2005 |
Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Disease Models, Animal; Heart Rate; Heart Ventricles; Hypertension; Kidney; Kidney Diseases; Male; Nitrendipine; Organ Size; Proteinuria; Quinapril; Rats; Rats, Inbred SHR; Tetrahydroisoquinolines; Time Factors | 2006 |
Angiotensin converting enzyme inhibitors and the otolaryngologist.
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cough; Dose-Response Relationship, Drug; Enalapril; Humans; Hypertension; Isoquinolines; Kidney Diseases; Lisinopril; Otolaryngology; Quinapril; Tetrahydroisoquinolines | 1995 |
Improved survival in rats administered NG-nitro L-arginine methyl ester due to converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Enzyme Inhibitors; Isoquinolines; Kidney; Kidney Diseases; Kidney Function Tests; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Quinapril; Rats; Rats, Wistar; Tetrahydroisoquinolines | 1996 |
Effects of dehydroepiandrosterone and quinapril on nephropathy in obese Zucker rats.
Topics: Actins; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Creatinine; Dehydroepiandrosterone; Diuresis; Isoquinolines; Kidney; Kidney Diseases; Muscle, Smooth; Natriuresis; Obesity; Organ Size; Proteinuria; Quinapril; Rats; Rats, Zucker; Tetrahydroisoquinolines; Thinness; Tissue Distribution | 2001 |
Renal tubulointerstitial damage caused by persistent proteinuria is attenuated in AT1-deficient mice: role of endothelin-1.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bosentan; Endothelins; Extracellular Matrix; Isoquinolines; Kidney; Kidney Diseases; Kidney Tubules; Kinetics; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Proteinuria; Quinapril; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Reference Values; RNA, Messenger; Serum Albumin, Bovine; Sulfonamides; Tetrahydroisoquinolines; Transcription Factor AP-1; Transforming Growth Factor beta | 2001 |
The pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients with various degrees of renal function.
Topics: Administration, Oral; Adolescent; Adult; Aged; Drug Administration Schedule; Half-Life; Humans; Isoquinolines; Kidney Diseases; Metabolic Clearance Rate; Middle Aged; Quinapril; Tetrahydroisoquinolines | 1992 |